Byetta 5 micrograms solution for injection, prefilled pen. Byetta 10 micrograms solution for injection, prefilled pen.
Last Updated on eMC 10-Aug-2016 View document | AstraZeneca UK Limited Contact details
Versions
- 10-Aug-2016 to Current
- 08-Jan-2016 to 10-Aug-2016
- 18-Jun-2015 to 08-Jan-2016
- 30-Oct-2014 to 18-Jun-2015
- 06-Aug-2014 to 30-Oct-2014
- 08-May-2014 to 06-Aug-2014
- 16-Jan-2014 to 08-May-2014
- 18-Oct-2013 to 16-Jan-2014
- 28-Mar-2013 to 18-Oct-2013
- 03-Jul-2012 to 28-Mar-2013
- 30-Mar-2012 to 03-Jul-2012
- 30-Sep-2011 to 30-Mar-2012
- 27-Sep-2010 to 30-Sep-2011
- 07-Jun-2010 to 27-Sep-2010
- 19-Mar-2009 to 07-Jun-2010
- 28-Oct-2008 to 19-Mar-2009
- 29-Apr-2008 to 28-Oct-2008
- 18-Feb-2008 to 29-Apr-2008
- 09-Jan-2008 to 18-Feb-2008
- 10-Sep-2007 to 09-Jan-2008
- 02-Jan-2007 to 10-Sep-2007
When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.
Updated on 10-Aug-2016 and displayed until Current
Reasons for adding or updating:
- Change to section 2 - what you need to know - warnings and precautions
- Change to section 2 - interactions with other medicines, food or drink
- Change to section 2 - pregnancy, breast feeding and fertility
- Change to section 3 - use in children/adolescents
- Change to section 3 - overdose, missed or forgotten doses
- Change to section 4 - possible side effects
- Change to section 6 - date of revision
- Change to other sources of information section
- Correction of spelling/typing errors
- Improved presentation of PIL
Updated on 08-Jan-2016 and displayed until 10-Aug-2016
Reasons for adding or updating:
- Change to section 6 - date of revision
- Change to section 4 - possible side effects
Updated on 18-Jun-2015 and displayed until 08-Jan-2016
Reasons for adding or updating:
- Change to section 4 - how to report a side effect
- Change to section 6 - manufacturer
- Change to section 6 - date of revision
Updated on 30-Oct-2014 and displayed until 18-Jun-2015
Reasons for adding or updating:
- Correction of spelling/typing errors
Updated on 06-Aug-2014 and displayed until 30-Oct-2014
Reasons for adding or updating:
- Change to section 6 - marketing authorisation holder
- Change to section 6 - date of revision
Updated on 08-May-2014 and displayed until 06-Aug-2014
Reasons for adding or updating:
- Change to section 4 - possible side effects
- Change to section 4 - how to report a side effect
- Change to section 6 - date of revision
Updated on 16-Jan-2014 and displayed until 08-May-2014
Reasons for adding or updating:
- Change to section 4 - possible side effects
- Change to section 4 - how to report a side effect
- Change to section 6 - date of revision
- Improved presentation of PIL
Updated on 18-Oct-2013 and displayed until 16-Jan-2014
Reasons for adding or updating:
- Change to section 6 - manufacturer
- Change to section 6 - date of revision
- Change to other sources of information section
Updated on 28-Mar-2013 and displayed until 18-Oct-2013
Reasons for adding or updating:
- Change to section 3 - use in children/adolescents
- Change to section 4 - possible side effects
- Change to section 6 - marketing authorisation holder
- Change to section 6 - date of revision
Updated on 03-Jul-2012 and displayed until 28-Mar-2013
Reasons for adding or updating:
- Change/addition of instructions for reconstitution and/ or administration
- Change to date of revision
Updated on 30-Mar-2012 and displayed until 03-Jul-2012
Reasons for adding or updating:
- Change to date of revision
- Change to, or new, use for medicine
- Change to warnings or special precautions for use
- Change to storage instructions
- Change to side-effects
- Change to information about driving or using machinery
- Change/addition of instructions for reconstitution and/ or administration
Updated on 30-Sep-2011 and displayed until 30-Mar-2012
Reasons for adding or updating:
- Change to how the medicine works
- Change to warnings or special precautions for use
- Change to storage instructions
- Change to side-effects
- Change to drug interactions
Updated on 27-Sep-2010 and displayed until 30-Sep-2011
Reasons for adding or updating:
- Change to date of revision
- Change to, or new, use for medicine
- Change to side-effects
- Change to manufacturer contact details
Updated on 07-Jun-2010 and displayed until 27-Sep-2010
Reasons for adding or updating:
- Change to date of revision
- Change to side-effects
Updated on 19-Mar-2009 and displayed until 07-Jun-2010
Reasons for adding or updating:
- Change to date of revision
- Change to side-effects
Updated on 28-Oct-2008 and displayed until 19-Mar-2009
Reasons for adding or updating:
- Change to Further Information section
- Change to date of revision
Updated on 29-Apr-2008 and displayed until 28-Oct-2008
Reasons for adding or updating:
- Transfer to upgraded management system
Updated on 18-Feb-2008 and displayed until 29-Apr-2008
Reasons for adding or updating:
- Change to warnings or special precautions for use
- Change to side-effects
- Change to date of revision
Updated on 09-Jan-2008 and displayed until 18-Feb-2008
Reasons for adding or updating:
- Change to drug interactions
- Change to date of revision
Updated on 10-Sep-2007 and displayed until 09-Jan-2008
Reasons for adding or updating:
- Change to storage instructions
- Change to date of revision
Updated on 02-Jan-2007 and displayed until 10-Sep-2007
Reasons for adding or updating:
- New PIL for new product
AstraZeneca UK Limited
Horizon Place, 600 Capability Green, Luton, Bedfordshire, LU1 3LU
+44 (0)1582 838 000
+44 (0)1582 838 003
+44 (0)1582 836 000
0800 783 0033
+44 (0)1582 837 837
Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Active ingredients
Legal categories
This site uses cookies. By continuing to browse the site you are agreeing to our policy on the use of cookies. Continue